Moreover, VEGF-A upregulation in microsatellite stable colorectal cancers promotes resistance to anti-PD-1 immunotherapy by antagonizing the effector function of CD8 T cells and favoring expansion of exhCD8 T cells via induction of a TOX-mediated transcriptional program (69). This evidence concerns the gene PDCD1 and colorectal cancer.